VANCO 125 mg (Vancomycin hydrochloride 125 mg (base))
Pill imprint VANCO 125 mg has been identified as Vancomycin hydrochloride 125 mg (base).
Vancomycin is used in the treatment of methicillin-resistant staphylococcus aureus infection; skin or soft tissue infection; bone infection; bacterial infection; sepsis (and more), and belongs to the drug class glycopeptide antibiotics. Risk cannot be ruled out during pregnancy. Vancomycin 125 mg (base) is not a controlled substance under the Controlled Substance Act (CSA).
- Imprint:
- VANCO 125 mg
- Strength:
- 125 mg (base)
- Color:
- Gray / Gray
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- Glycopeptide antibiotics
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- APP Pharmaceuticals, Inc.
More about vancomycin
Consumer resources
- Vancomycin
- Vancomycin capsules
- Vancomycin solution
- Vancomycin injection
- Vancomycin (Advanced Reading)
- Vancomycin Intravenous, Injection (Advanced Reading)
- Other brands: Vancocin, Vancocin HCl Pulvules, Vancocin HCl
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
